229 related articles for article (PubMed ID: 19619893)
1. Natural history of persistent high-risk human papillomavirus infections in Korean women.
Bae J; Seo SS; Park YS; Dong SM; Kang S; Myung SK; Park SY
Gynecol Oncol; 2009 Oct; 115(1):75-80. PubMed ID: 19619893
[TBL] [Abstract][Full Text] [Related]
2. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.
Dalstein V; Riethmuller D; Prétet JL; Le Bail Carval K; Sautière JL; Carbillet JP; Kantelip B; Schaal JP; Mougin C
Int J Cancer; 2003 Sep; 106(3):396-403. PubMed ID: 12845680
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia.
Hosseini MS; Khosravi D; Farzaneh F; Ebrahimi A; Arab M; Ashraf Ganjoie T; Jamdar F; Moridi A; Chehrazi M
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3071-3075. PubMed ID: 30485943
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus infection in women with and without cervical cancer in Tbilisi, Georgia.
Alibegashvili T; Clifford GM; Vaccarella S; Baidoshvili A; Gogiashvili L; Tsagareli Z; Kureli I; Snijders PJ; Heideman DA; van Kemenade FJ; Meijer CJ; Kordzaia D; Franceschi S
Cancer Epidemiol; 2011 Oct; 35(5):465-70. PubMed ID: 21292583
[TBL] [Abstract][Full Text] [Related]
6. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.
Arbyn M; Buntinx F; Van Ranst M; Paraskevaidis E; Martin-Hirsch P; Dillner J
J Natl Cancer Inst; 2004 Feb; 96(4):280-93. PubMed ID: 14970277
[TBL] [Abstract][Full Text] [Related]
7. [Association between high-risk human papillomavirus DNA load and different histological grades of cervical neoplasia].
Zhao FH; Hu SY; Wang SM; Chen F; Zhang X; Zhang WH; Pan QJ; Qiao YL
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):565-70. PubMed ID: 19954065
[TBL] [Abstract][Full Text] [Related]
8. HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3.
Zielinski GD; Rozendaal L; Voorhorst FJ; Berkhof J; Snijders PJ; Risse EJ; Runsink AP; de Schipper FA; Meijer CJ
Gynecol Oncol; 2003 Oct; 91(1):67-73. PubMed ID: 14529664
[TBL] [Abstract][Full Text] [Related]
9. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.
Denise Zielinski G; Snijders PJ; Rozendaal L; Voorhorst FJ; Runsink AP; de Schipper FA; Meijer CJ
J Pathol; 2001 Oct; 195(3):300-6. PubMed ID: 11673826
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears.
Derchain SF; Rabelo-Santos SH; Sarian LO; Zeferino LC; de Oliveira Zambeli ER; do Amaral Westin MC; de Angelo Andrade LA; Syrjänen KJ
Gynecol Oncol; 2004 Dec; 95(3):618-23. PubMed ID: 15581973
[TBL] [Abstract][Full Text] [Related]
11. Adeno-associated virus infection and cervical neoplasia: is there a protective role against human papillomavirus-related carcinogenesis?
Agorastos T; Chrisafi S; Lambropoulos AF; Mikos T; Constandinides TC; Schlehofer JR; Schlehofer B; Kotsis A; Bontis JN
Eur J Cancer Prev; 2008 Aug; 17(4):364-8. PubMed ID: 18562963
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear.
Arora R; Kumar A; Prusty BK; Kailash U; Batra S; Das BC
Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):104-9. PubMed ID: 15950365
[TBL] [Abstract][Full Text] [Related]
13. DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia.
Lie AK; Risberg B; Borge B; Sandstad B; Delabie J; Rimala R; Onsrud M; Thoresen S
Gynecol Oncol; 2005 Jun; 97(3):908-15. PubMed ID: 15943992
[TBL] [Abstract][Full Text] [Related]
14. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
[TBL] [Abstract][Full Text] [Related]
15. Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear.
Monsonego J; Pollini G; Evrard MJ; Sednaoui P; Monfort L; Quinzat D; Dachez R; Syrjänen K
Int J STD AIDS; 2008 Jun; 19(6):385-92. PubMed ID: 18595876
[TBL] [Abstract][Full Text] [Related]
16. High-risk HPV DNA detection by Hybrid Capture II. An adjunctive test for mildly abnormal cytologic smears in women > or = 50 years of age.
Lin CT; Tseng CJ; Lai CH; Hsueh S; Huang HJ; Law KS
J Reprod Med; 2000 Apr; 45(4):345-50. PubMed ID: 10804494
[TBL] [Abstract][Full Text] [Related]
17. Association between high-risk human papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women.
Hernández-Hernández DM; Ornelas-Bernal L; Guido-Jiménez M; Apresa-Garcia T; Alvarado-Cabrero I; Salcedo-Vargas M; Mohar-Betancourt A; Garcia-Carranca A
Gynecol Oncol; 2003 Aug; 90(2):310-7. PubMed ID: 12893192
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
Ouh YT; Min KJ; Cho HW; Ki M; Oh JK; Shin SY; Hong JH; Lee JK
J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
[TBL] [Abstract][Full Text] [Related]
19. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
Kjær SK; Frederiksen K; Munk C; Iftner T
J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
[TBL] [Abstract][Full Text] [Related]
20. The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population.
Inoue M; Sakaguchi J; Sasagawa T; Tango M
Int J Gynecol Cancer; 2006; 16(3):1007-13. PubMed ID: 16803477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]